摘要
目的评价血管紧张素转换酶抑制剂(ACEI)卡托普利防治急性心肌梗死(AMI)后左室重塑(LVR)作用。方法对使用ACEI治疗的26例AMI患者(治疗组)与除常规治疗未用ACEI治疗的26例AMI患者(对照组)6个月后NYHA分级Ⅲ级的心衰症状发生率进行比较。结果治疗组1例发生心力衰竭再住院,对照组6例发生心力衰竭再住院,两组存在显著差异(P<0.05)。结论ACEI防治心肌梗死后左室重塑疗效确切。
Objective To evaluate the function of angiotensin converting enzyme inhibitor(ACEI) captopril on preventing left ventricular from remodeling after acute myocardial infarction (AMI). Methods The incidence of symptom of chronic heart failure of the third degree from NYHA in 26 cases who had captopril(the investigated group) was compared with that in 26 cases who did not has captopril (the control group) within six months after acute myocardial infarction. Resuits There is a patient suffering from chronic heart failure in the investigated group while there are six patients in the control group.The two groups show extremely statistical significance(P 〈 0.05), Conclusion The results indicate a significant effect of captopril on preventing left ventricular from remodehng occurred after acute myocardial infarction.
出处
《中国临床保健杂志》
CAS
2005年第4期332-333,共2页
Chinese Journal of Clinical Healthcare
关键词
卡托普利
心肌梗塞
左室重构
Captopril
Myocardial infarction
Ventricular remodeling